Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266312.RAbUCSZx0PR-Rwe5gpJrtzcRW-Xm3bG7F_to3hV1V17jQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266312.RAbUCSZx0PR-Rwe5gpJrtzcRW-Xm3bG7F_to3hV1V17jQ130_assertion type Assertion NP1266312.RAbUCSZx0PR-Rwe5gpJrtzcRW-Xm3bG7F_to3hV1V17jQ130_head.
- NP1266312.RAbUCSZx0PR-Rwe5gpJrtzcRW-Xm3bG7F_to3hV1V17jQ130_assertion description "[In FMEN1, plasma Chr-A was highest in subjects with Zollinger-Ellison syndrome (ZES, 120 +/- 127; no ZES, 30 +/- 33 (P less than 0.0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266312.RAbUCSZx0PR-Rwe5gpJrtzcRW-Xm3bG7F_to3hV1V17jQ130_provenance.
- NP1266312.RAbUCSZx0PR-Rwe5gpJrtzcRW-Xm3bG7F_to3hV1V17jQ130_assertion evidence source_evidence_literature NP1266312.RAbUCSZx0PR-Rwe5gpJrtzcRW-Xm3bG7F_to3hV1V17jQ130_provenance.
- NP1266312.RAbUCSZx0PR-Rwe5gpJrtzcRW-Xm3bG7F_to3hV1V17jQ130_assertion SIO_000772 2571619 NP1266312.RAbUCSZx0PR-Rwe5gpJrtzcRW-Xm3bG7F_to3hV1V17jQ130_provenance.
- NP1266312.RAbUCSZx0PR-Rwe5gpJrtzcRW-Xm3bG7F_to3hV1V17jQ130_assertion wasDerivedFrom befree-2016 NP1266312.RAbUCSZx0PR-Rwe5gpJrtzcRW-Xm3bG7F_to3hV1V17jQ130_provenance.
- NP1266312.RAbUCSZx0PR-Rwe5gpJrtzcRW-Xm3bG7F_to3hV1V17jQ130_assertion wasGeneratedBy ECO_0000203 NP1266312.RAbUCSZx0PR-Rwe5gpJrtzcRW-Xm3bG7F_to3hV1V17jQ130_provenance.